ArticlebioRxiv : the preprint server for biology2026
ProteoformTracker: an interactive tool for planning proteoform detectability in top-down and middle-down proteomics.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Characterizing proteome complexity in disease contexts is essential for understanding molecular mechanisms and advancing therapeutic development. Mass spectrometry (MS)-based top-down and middle-down proteomics (TDP/MDP) can resolve intact proteoforms - protein molecules carrying a unique combination of isoform sequence and post-translational modifications (PTMs); however, their technical complexity and modest throughput present challenges for experimental planning and limit their broader application. Here, we present ProteoformTracker, an online web tool that prospectively models MS signal and evaluates the feasibility of using TDP/MDP to distinguish a target proteoform from related isoforms and the background proteome. ProteoformTracker takes as input a gene's annotated isoforms, a novel long-read/assembled transcript, or an rMATS alternative-splicing event, with or without user-specified PTMs, and predicts each proteoform's MS1 charge-state envelope and exact isotope pattern, scores per-bond MS2 fragmentation propensity, and searches the full reference human proteome for confounding proteins that could share the target's intact mass or a charge-state m/z peak. ProteoformTracker also supports middle-down workflows via simulated partial protease digestion. Results are rendered as interactive, zoomable MS1 and MS2 visualizations with live resolvability and fragment-ion statistics, letting users incorporate outside evidence into which confounders they compare against. We envision ProteoformTracker as a useful tool for users to plan TDP/MDP experiments targeting specific proteoforms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.